INUS
Straddle Chart

Markets / Mutual funds / Other ETFs

Mutual fundsSIF

ICICI Prudential Nifty Healthcare ETF - Regular Plan - Growth

NAVs of 8 Nov 2026

ICICI Prudential Mutual Fund · Index & ETFs fund · Regular plan · Growth

Other ETFsRegular · Growth
NAV · 6 Nov 2026
₹173.7825 ▲ 0.67%
ICICI Prudential Mutual Fund
Fund size₹232 crJuly - September 2026
1-month range₹157.93 – 173.78
1 year+15.62%rank 13 of 176
Expense ratio0.18%regular plan, a year
5 years+15.06%a year

What the fund does

The investment objective of the scheme is to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

BenchmarkNifty Healthcare TRI
Launched18 May 2021
Fund houseICICI Prudential Mutual Fund

NAV history

159166173 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+2.93%avg 5.4%
1 month
+5.43%avg 4.2%
3 months
+1.30%avg -2.1%
6 months
+10.06%avg -0.7%
This year
+16.07%avg -4.5%
1 year
+15.62%avg -1.8% · #13/176
3 years (a year)
+21.94%avg 1.2% · #8/111
5 years (a year)
+15.06%avg -2.0% · #7/60

Bars: this plan; the thin mark is the Other ETFs average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+4.0
2025-6.2-7.8+7.8+1.1+0.4+3.8+3.3-3.3-1.3+3.8+2.3-2.6
2026-5.1+7.2-4.5+5.0+3.2+4.9+4.0+1.1-4.8+1.9+2.9

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks75.8%of the fund
Equity100.0%stocks and equity derivatives
Debt & cash0.0%everything else

Where the money is

Equity 100.0%Short -0.0%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
81.1%
Healthcare Services
18.9%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held100.0%100.0%-0.02
Cash & others0.0%0.0%+0.02
Top 10 stocks75.8%77.3%-1.50
Number of stocks20200
New stocks 2
  • Gland Pharma Ltd.2.04%
  • Krishna Institute of Medical Sciences1.76%
Stocks sold off 2
  • Piramal Pharma Ltd.was 1.15%
  • Syngene International Ltd.was 0.66%
Bought more 2
  • Dr. Reddy's Laboratories Ltd.+0.59
  • Laurus Labs Ltd.+0.41
Cut back 5
  • Sun Pharmaceutical Industries Ltd.-1.08
  • MAX Healthcare Institute Ltd-0.56
  • Fortis Healthcare Ltd.-0.52
  • Apollo Hospitals Enterprise Ltd.-0.45
  • Biocon Ltd.-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Ltd.
INE044A01036		Pharmaceuticals & Biotechnology17.00%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology10.44%
Apollo Hospitals Enterprise Ltd.
INE437A01024		Healthcare Services7.43%
Laurus Labs Ltd.
INE947Q01028		Pharmaceuticals & Biotechnology6.82%
Cipla Ltd.
INE059A01026		Pharmaceuticals & Biotechnology6.69%
Dr. Reddy's Laboratories Ltd.
INE089A01031		Pharmaceuticals & Biotechnology6.65%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology6.24%
MAX Healthcare Institute Ltd
INE027H01010		Healthcare Services6.12%
Lupin Ltd.
INE326A01037		Pharmaceuticals & Biotechnology4.36%
Aurobindo Pharma Ltd.
INE406A01037		Pharmaceuticals & Biotechnology4.08%
Fortis Healthcare Ltd.
INE061F01013		Healthcare Services3.55%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology3.11%
Alkem Laboratories Ltd.
INE540L01014		Pharmaceuticals & Biotechnology2.75%
Zydus Lifesciences Ltd.
INE010B01027		Pharmaceuticals & Biotechnology2.54%
Mankind Pharma Ltd.
INE634S01028		Pharmaceuticals & Biotechnology2.51%
IPCA Laboratories Ltd.
INE571A01038		Pharmaceuticals & Biotechnology2.37%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology2.28%
Gland Pharma Ltd.
INE068V01023		Pharmaceuticals & Biotechnology2.04%
Krishna Institute of Medical Sciences
INE967H01025		Healthcare Services1.76%
Abbott India Ltd.
INE358A01014		Pharmaceuticals & Biotechnology1.25%

Short positions 1

HoldingSector / type% of fund
Net Current Assets–-0.01%

Debt, money market and cash 1

HoldingSector / type% of fund
TREPS–0.04%

From the fund house's monthly portfolio (icicipruamc.com), as on 30 Sept 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.

Risk

Volatility14.1%yearly, from daily NAVs
Worst fall-17.82%31 Aug 2021 → 30 Jun 2022

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 31 May 2021).

Fund details

Fund size (average AUM, July - September 2026)₹232 cr across all plans
Fund houseICICI Prudential Mutual Fund
CategoryIndex & ETFs · Other ETFs
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.00% · Regular 0.18% (5 Nov 2026)
Minimum investmentDuring Ongoing/Continuous Offer: On Stock Exchanges: Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereof. Directly with the Mutual Fund: Investors can buy or sell units of the scheme in creation unit size and its multiples. Further, any application by investors, other than Market Makers, must be for an amount exceeding INR 25 crores. However, the aforementioned threshold of INR 25 crores shall not apply to investors falling under the following categories (until such time as may be specified by SEBI/AMFI): a. Schemes managed by Employee Provident Fund Organisation, India; b. Recognised Provident Funds, approved Gratuity funds and approved superannuation funds under Income Tax Act, 1961. All direct transactions in units of the Scheme by eligible investors with the AMC/the Fund shall be at intra-day NAV based on the actual execution price of the underlying portfolio..
Scheme code (AMFI)148957
ISININF109KC1Q72
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Top Other ETFs funds (regular plans)

Fund1 year3 years (a year)
ICICI PRUDENTIAL SILVER ETF+23.64%+36.23%
Nippon India Silver ETF+23.37%+35.89%
HDFC Silver ETF+23.10%+35.72%
Motilal Oswal Nasdaq Q50 ETF+31.47%+29.58%
Motilal Oswal Nasdaq 100 ETF+11.67%+26.04%
Nippon India Nifty Pharma ETF+26.02%+23.86%
Motilal Oswal BSE Healthcare ETF+16.43%+23.34%
ICICI Prudential Nifty Healthcare ETF+15.62%+21.94%

All Other ETFs funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of ICICI Prudential Nifty Healthcare ETF - Regular Plan - Growth today?

₹173.7825 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of ICICI Prudential Nifty Healthcare ETF - Regular Plan - Growth?

1 year: 15.62%, 3 years: 21.94% a year, 5 years: 15.06% a year

How does ICICI Prudential Nifty Healthcare ETF rank in its category?

13 of 176 Other ETFs funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.